Regarding the screening tests that we usually use in surveillance for HCC, another aspect to discuss is that AFP measurement will probably have a better performance in patients with cured hepatitis C, particularly with an increase in its specificity. The gene discussed is AFP; the disease is hepatocellular carcinoma.